Change in the Tecan Board of Directors

03-05-2009: Change in the Board of Directors of Tecan: in line with a periodic renewal, the Tecan Board of Directors proposes to the ordinary Annual General Meeting on 22 April 2009 Heinrich Fischer, Gérard Vaillant, Prof. Dr. Peter Ryser und Dr. Jürg Meier for re-election and Rolf A. Classon, Dr. Lukas Braunschweiler and Dominique F. Baly as new members of the Board. Rolf Classon is expected to succeed Mike Baronian and take over as Chairman.

Rolf A. Classon, born 1945, is on the Board of various US and European companies in the life science sector. Up until 2006 he held various top management positions at large international corporations in the pharmaceutical sector, including CEO at Bayer Healthcare and CEO of Hillenbrand Industries. A Swedish citizen, he holds a degree in chemical engineering from the University of Gothenburg.

Dr. Lukas Braunschweiler, born 1956 and Swiss citizen, graduated from the Swiss Federal Institute of Technology (ETH Zurich) in physical chemistry. He was appointed CEO of Ruag Holding AG in December 2008 and will take up this role in June 2009. From 2002 to date he has been Delegate of the Board of Directors and CEO of Dionex, a listed US-based manufacturer of laboratory instruments. He previously held executive positions at a number of major high-tech companies including Mettler-Toledo and Landis & Gyr.

Dominique F. Baly, born 1949, graduated from the University Louis Pasteur in Strasbourg, France, in Pharmacy. He is a French and US citizen. From 1972 until 2008, Dominique F. Baly held various top management positions at Millipore Corporation in Europe and in the US, including President of the Bioscience Division, President of the Laboratory Water Division and Vice President & General Manager, Millipore Europe.